Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases.
Aliment Pharmacol Ther
; 46(11-12): 1037-1053, 2017 12.
Article
in En
| MEDLINE
| ID: mdl-29027257
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Gastrointestinal Agents
/
Inflammatory Bowel Diseases
/
Drug Monitoring
/
Adalimumab
/
Infliximab
Type of study:
Guideline
/
Prognostic_studies
Limits:
Humans
Country/Region as subject:
Oceania
Language:
En
Journal:
Aliment Pharmacol Ther
Journal subject:
FARMACOLOGIA
/
GASTROENTEROLOGIA
/
TERAPIA POR MEDICAMENTOS
Year:
2017
Document type:
Article
Affiliation country:
Australia
Country of publication:
Reino Unido